These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23176506)

  • 1. Using a bacteriocin structure to engineer a phage lysin that targets Yersinia pestis.
    Lukacik P; Barnard TJ; Buchanan SK
    Biochem Soc Trans; 2012 Dec; 40(6):1503-6. PubMed ID: 23176506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural engineering of a phage lysin that targets gram-negative pathogens.
    Lukacik P; Barnard TJ; Keller PW; Chaturvedi KS; Seddiki N; Fairman JW; Noinaj N; Kirby TL; Henderson JP; Steven AC; Hinnebusch BJ; Buchanan SK
    Proc Natl Acad Sci U S A; 2012 Jun; 109(25):9857-62. PubMed ID: 22679291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineering a Lysin with Intrinsic Antibacterial Activity (LysMK34) by Cecropin A Fusion Enhances Its Antibacterial Properties against Acinetobacter baumannii.
    Abdelkader K; Gutiérrez D; Tamés-Caunedo H; Ruas-Madiedo P; Safaan A; Khairalla AS; Gaber Y; Dishisha T; Briers Y
    Appl Environ Microbiol; 2022 Jan; 88(1):e0151521. PubMed ID: 34669452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacteriophage lysins as effective antibacterials.
    Fischetti VA
    Curr Opin Microbiol; 2008 Oct; 11(5):393-400. PubMed ID: 18824123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of net charge on catalytic domain and influence of cell wall binding domain on bactericidal activity, specificity, and host range of phage lysins.
    Low LY; Yang C; Perego M; Osterman A; Liddington R
    J Biol Chem; 2011 Sep; 286(39):34391-403. PubMed ID: 21816821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysocins: Bioengineered Antimicrobials That Deliver Lysins across the Outer Membrane of Gram-Negative Bacteria.
    Heselpoth RD; Euler CW; Schuch R; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jun; 63(6):. PubMed ID: 30962344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of the direct antimicrobial activity of Lysep3 against Escherichia coli by inserting cationic peptides into its C terminus.
    Ma Q; Guo Z; Gao C; Zhu R; Wang S; Yu L; Qin W; Xia X; Gu J; Yan G; Lei L
    Antonie Van Leeuwenhoek; 2017 Mar; 110(3):347-355. PubMed ID: 27943012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genetic screen to identify bacteriophage lysins.
    Schuch R; Fischetti VA; Nelson DC
    Methods Mol Biol; 2009; 502():307-19. PubMed ID: 19082564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant bacteriophage lysins as antibacterials.
    Fenton M; Ross P; McAuliffe O; O'Mahony J; Coffey A
    Bioeng Bugs; 2010; 1(1):9-16. PubMed ID: 21327123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence-Function Relationships in Phage-Encoded Bacterial Cell Wall Lytic Enzymes and Their Implications for Phage-Derived Product Design.
    Vázquez R; García E; García P
    J Virol; 2021 Jun; 95(14):e0032121. PubMed ID: 33883227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysins breaking down the walls of Gram-negative bacteria, no longer a no-go.
    Gutiérrez D; Briers Y
    Curr Opin Biotechnol; 2021 Apr; 68():15-22. PubMed ID: 33053478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 1.6 A crystal structure of the catalytic domain of PlyB, a bacteriophage lysin active against Bacillus anthracis.
    Porter CJ; Schuch R; Pelzek AJ; Buckle AM; McGowan S; Wilce MC; Rossjohn J; Russell R; Nelson D; Fischetti VA; Whisstock JC
    J Mol Biol; 2007 Feb; 366(2):540-50. PubMed ID: 17182056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages that infect Gram-negative bacteria as source of signal-arrest-release motif lysins.
    Gontijo MTP; Vidigal PMP; Lopez MES; Brocchi M
    Res Microbiol; 2021 Mar; 172(2):103794. PubMed ID: 33347948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lysins: the arrival of pathogen-directed anti-infectives.
    Pastagia M; Schuch R; Fischetti VA; Huang DB
    J Med Microbiol; 2013 Oct; 62(Pt 10):1506-1516. PubMed ID: 23813275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and uptake mechanism of bacteriocins targeting peptidoglycan renewal.
    Zeth K
    Biochem Soc Trans; 2012 Dec; 40(6):1560-5. PubMed ID: 23176517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and mechanistic studies of pesticin, a bacterial homolog of phage lysozymes.
    Patzer SI; Albrecht R; Braun V; Zeth K
    J Biol Chem; 2012 Jul; 287(28):23381-96. PubMed ID: 22593569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phage-derived lysins as therapeutic agents against multidrug-resistant Enterococcus faecalis.
    Gu J; Xi H; Cheng M; Han W
    Future Microbiol; 2018 Mar; 13():275-278. PubMed ID: 29441802
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of Phage Lysins That Effectively Kill Pseudomonas aeruginosa in Mouse Models of Lung and Skin Infection.
    Raz A; Serrano A; Hernandez A; Euler CW; Fischetti VA
    Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phages and engineered lysins as an effective tool to combat Gram-negative foodborne pathogens.
    Kocot AM; Briers Y; Plotka M
    Compr Rev Food Sci Food Saf; 2023 May; 22(3):2235-2266. PubMed ID: 37009835
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.